Default company panoramic image

HOCOR Cardiovascular Technologies

Our life-saving temporary heart valve catheter is 10 pigs away from FDA approval for human use.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Honolulu, HI, USA
  • Currency USD
  • Founded August 2007
  • Employees 1
  • Incorporation Type Not Incorporated
  • Website

Company Summary

HOCOR has developed a temporary heart valve catheter that can save lives in an emergency. Our invention has been awarded 7 patents (6US, 1EU), and the technology has been further validated in 8 medical journal publications. The FDA has written us a letter stating their approval for human use after the last round study using 10 pigs and the clinical prototype. The cost of this final step toward human use in the US is estimated to be $500,000.


  • Default avatar
    Paul C. Ho
    President, CEO

    Founder of HOCOR and inventor of the HOCOR system, Dr. Ho practices Clinical and Interventional Cardiology in Honolulu, Hawaii and has performed over 5,000 percutaneous cardiac procedures. He has been involved in numerous clinical studies of cardiovascular devices. Trained as a Biomedical Engineer at the University of Pennsylvania, he received his Medicine and Cardiology training at the Dartmouth and Harvard Medical Schools.


  • Default avatar
    Stewart Pressman, JD McCorriston Miller Mukai MacKinnon LLP
    Default avatar
    Alan Schlissel, JD, MBA KMH-LLP